Pluripotent stem cell (PSC) research is an expanding field that has the potential to change the way human diseases are studied and treated. See More The ability to differentiate embryonic stem (ES) cells and induced pluripotent stem (iPS) cells to specific downstream cell types opens up new avenues for drug development and regenerative medicine. From generation of iPS cells to maintenance, differentiation, characterization, and cryopreservation of ES and iPS cells, see how you can "Maximize Your Pluripotential" with the most complete, defined system for ES and iPS cell culture. For help with your hPSC workflow decision making, use our infographics to find the right reagents for you.
Read this mini-review to learn more about Pluripotent Stem Cells.See Less
Explore These Resources
Genome Editing Reveals a Role for OCT4 in Human Embryogenesis
"Researchers used CRISPR–Cas9-mediated genome editing to investigate the function of the pluripotency transcription factor OCT4 during human embryogenesis. They identified an efficient OCT4-targeting guide RNA using an inducible human embryonic stem cell-based system and microinjection of mouse zygotes."ESC & iPSC News Volume 12.37, September 20, 2017. Read full issue at